HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Infectious Disease
Guideline
Capmatinib identified as a promising candidate for repurposing against Mpox via in silico screening
Computer models identify potential new drugs to fight Mpox
This guideline provides an in silico study identifying capmatinib, nebivolol, and tucatinib as potential candidates for targeting MPXV thymi…
Researchers used computer simulations to identify three existing drugs that might be repurposed to treat Mpox infections.
Frontiers
Sep 14, 2026
Cardiology
Meta-analysis
Meta-analysis finds beta-blockers may reduce cardiotoxicity risk during cancer therapy
Heart-Protecting Meds Show Promise for Cancer Patients
A meta-analysis of 19 RCTs in patients receiving anthracyclines and/or trastuzumab found beta-blockers improved LVEF (WMD=2.19) and reduced…
Two specific heart medications stand out as the most effective shields against heart damage caused by powerful cancer treatments.
Frontiers
Apr 13, 2026